Correlation of clinicopathological parameters with presence of human epidermal growth factor receptor in adenocarcinoma of stomach

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter B. Kandel
Citation Annals of Oncology (2016) 27 (2): 86-101. 10.1093/annonc/mdw201
Authors B. Kandel, Y. Singh
  • Tribhuvan University Teaching Hospital, Kathmandu, Nepal, /

Abstract

Adenocarcinoma of stomach is the fifth most common cancer worldwide and fourth most common cancer in Nepal. Prognosis of gastric cancer is poor with overall five year survival less than 30%. Important factors for poor prognosis are advanced disease at diagnosis, histological grade, perineural invasion, lymphovascular invasion. Recently, human epidermal growth factor receptor2 (HER2) has been studied as a prognostic marker for gastric cancer. This study was conducted to evaluate to prognostic role of HER2 in gastric cancer.